Table 3. . Resource consumption per study group after propensity score matching.

Study groups PSM Patients	Apixaban (n = 2160)	Acenocoumarol (n = 2160)	p-value
Healthcare resources
Visits
Primary care visits	6.3 (4.3)	10.9 (7)	<0.001
Nursing visits	3 (2.3)	14.7 (9.8)	<0.001
Specialist visit	2.1 (1.9)	2.8 (2)	<0.001
Cardiology	0.4 (0.6)	0.5 (0.6)	<0.001
Intern medicine	0.3 (0.5)	0.4 (0.5)	0.009
Endocrinology	0.3 (0.5)	0.4 (0.5)	0.003
Vascular	0.3 (0.5)	0.4 (0.5)	<0.001
Neurology	0.4 (0.6)	0.5 (0.6)	<0.001
Hematology	0 (0.1)	0.4 (0.5)	<0.001
Geriatrics	0.3 (0.5)	0.4 (0.5)	0.023
Emergency visits	0.2 (0.4)	0.3 (0.5)	<0.001
Hospitalizations
Hospitalizations (%)	6.6%	10.8%	<0.001
Days, mean (SD)	0.6 (2.5)	1.37 (4.2)	<0.001
Clinical tests and procedures
Laboratory tests	2.2 (1.6)	3.2 (2.3)	<0.001
Radiology	0.8 (0.8)	1 (0.8)	<0.001
Computerized tomography	0.3 (0.5)	1 (0.8)	<0.001
Nuclear magnetic resonance	0.3 (0.5)	0.8 (0.8)	<0.001
Other tests†	1.2 (1)	2.4 (1.7)	<0.001
Catheterization	0.2 (0.4)	0.2 (0.4)	0.154
Angioplasty	0.2 (0.4)	0.2 (0.4)	0.709
Endarterectomy	0 (0.1)	0.2 (0.4)	<0.001
Indirect resources
Temporary labor loss			<0.001
Labor loss (%)	12.4%	15.6%
Days, mean (SD)	1.7 (4.7)	2.5 (6.3)

Values expressed as a percentage or mean (SD).

^†Includes echocardiogram and Doppler echocardiography.

p: Statistical significance; PSM: Propensity score matching; SD: Standard deviation.